94 related articles for article (PubMed ID: 2202464)
21. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
22. [GM-CSF: its clinical administration; the treatment of aplasia].
Rossi Ferrini P; Grossi A; Santini V; Vannucchi AM
Haematologica; 1989 Oct; 74(5 Suppl):489-500. PubMed ID: 2512231
[No Abstract] [Full Text] [Related]
23. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
Asano Y; Shibuya T; Okamura S; Yamaga S; Otsuka T; Niho Y
Cancer Res; 1987 Nov; 47(21):5647-8. PubMed ID: 3499216
[TBL] [Abstract][Full Text] [Related]
24. Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients.
Palmeri S; Leonardi V; Danova M; Porta C; Ferrari S; Fincato G; Citarrella P
Haematologica; 1999 Nov; 84(11):1016-23. PubMed ID: 10553163
[TBL] [Abstract][Full Text] [Related]
25. [GM-CSF: target cells and their response kinetics].
Aglietta M; Piacibello W; Aprá F; Stacchini A; Sanavio F; Monzeglio C; Mossetti C; Bussolino F; Gavosto G
Haematologica; 1989 Oct; 74(5 Suppl):478-88. PubMed ID: 2512230
[No Abstract] [Full Text] [Related]
26. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
Hohaus S; Martin H; Wassmann B; Egerer G; Haus U; Färber L; Burger KJ; Goldschmidt H; Hoelzer D; Haas R
Bone Marrow Transplant; 1998 Oct; 22(7):625-30. PubMed ID: 9818688
[TBL] [Abstract][Full Text] [Related]
27. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia.
Zhang WG; Wang FX; Chen YX; Cao XM; He AL; Liu J; Ma XR; Zhao WH; Liu SH; Wang JL
Am J Hematol; 2008 Mar; 83(3):185-8. PubMed ID: 17899614
[TBL] [Abstract][Full Text] [Related]
28. A pilot study of priming with granulocyte macrophage colony-stimulating factor plus all-trans retinoic acid combined with remission induction chemotherapy in patients with acute myeloid leukemia.
Shin HJ; Chung JS; Choi YJ; Cho GJ
Am J Clin Oncol; 2009 Jun; 32(3):227-32. PubMed ID: 19433969
[TBL] [Abstract][Full Text] [Related]
29. Splenic hematopoiesis following GM-CSF therapy in a patient with hairy cell leukemia.
Lindemann A; Herrmann F; Mertelsmann R; Gamm H; Rumpelt HJ
Leukemia; 1990 Aug; 4(8):606-7. PubMed ID: 2201835
[No Abstract] [Full Text] [Related]
30. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
32. [GM-CSF: granulocyte and macrophage colony stimulating factor. A biologic agent with a great therapeutic potential in oncology].
Cortes-Funes H
Rev Clin Esp; 1990 Mar; 186(4):173-4. PubMed ID: 2195605
[No Abstract] [Full Text] [Related]
33. Treatment of poor-prognosis, newly diagnosed acute myeloid leukemia with ara-C and recombinant human granulocyte-macrophage colony-stimulating factor.
Estey EH; Dixon D; Kantarjian HM; Keating MJ; McCredie K; Bodey GP; Kurzrock R; Talpaz M; Freireich EJ; Deisseroth AB
Blood; 1990 May; 75(9):1766-9. PubMed ID: 2184901
[TBL] [Abstract][Full Text] [Related]
34. AIDS file. GM-CSF may boost WBC counts.
Conover AC
Am J Nurs; 1990 Apr; 90(4):29. PubMed ID: 2181877
[No Abstract] [Full Text] [Related]
35. GM-CSF treatment in aplasia after cytotoxic therapy.
Gattringer C; Thaler J; Drach J; Micksche M; Huber H
Onkologie; 1989 Feb; 12(1):16-8. PubMed ID: 2654787
[TBL] [Abstract][Full Text] [Related]
36. Necrotizing vasculitis at granulocyte-macrophage-colony-stimulating factor injection sites.
Farmer KL; Kurzrock R; Gutterman JU; Duvic M
Arch Dermatol; 1990 Sep; 126(9):1243-4. PubMed ID: 2204310
[No Abstract] [Full Text] [Related]
37. Perforation of an unsuspected cecal granulocytic sarcoma during therapy with granulocyte-macrophage colony-stimulating factor.
Evans C; Rosenfeld CS; Winkelstein A; Shadduck RK; Pataki KI; Oldham FB
N Engl J Med; 1990 Feb; 322(5):337-8. PubMed ID: 2404207
[No Abstract] [Full Text] [Related]
38. Treatment of RAEB-t with intensive chemotherapy and GM-CSF.
Brito-Babapulle F; Lord JA; Whitmore DN
Leuk Res; 1989; 13(7):605-7. PubMed ID: 2668647
[TBL] [Abstract][Full Text] [Related]
39. GM-CSF: intravenous versus subcutaneous treatment.
Aglietta M; Monzeglio C; Piacibello W; Aprá F; Stacchini A; Sanavio F; Mossetti C; Stern AC; Gavosto F
Leukemia; 1990 Jul; 4(7):523. PubMed ID: 2197516
[No Abstract] [Full Text] [Related]
40. Clinical trials referral resource. Protocols for elderly patients with acute myeloid leukemia.
Cheson BD
Oncology (Williston Park); 1991 Nov; 5(11):61-2, 65. PubMed ID: 1837230
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
